Riley Waggaman On March 25, TASS reported Russian pharmaceutical company Pharmasyntez, which produces Sputnik Light, was applying to manufacture a COVID drug based on a combination of nirmatrelvir and ritonavir. At the end of 2021, Russia’s health ministry included this drug combo on its list of approved COVID treatments. “Nirmatrelvir and ritonavir” is an antiviral drug developed by Pfizer …
Source